1. First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis. (December 2020) Authors: Landre, Thierry; Chouahnia, Kader; Des Guetz, Gaëtan; Duchemann, Boris; Assié, Jean-Baptiste; Chouaïd, Christos Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study). (October 2020) Authors: Assié, Jean-Baptiste; Corre, Romain; Levra, Matteo Giaj; Calvet, Christophe Yannick; Gaudin, Anne-Françoise; Grumberg, Valentine; Jouaneton, Baptiste; Cotté, François-Emery; Chouaïd, Christos Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PD-L1-expression patterns in large-cell neuroendocrine carcinoma of the lung: potential implications for use of immunotherapy in these patients: the GFPC 03-2017 "EPNEC" study. (July 2020) Authors: Arpin, Dominique; Charpentier, Marie-Christine; Bernardi, Marie; Monnet, Isabelle; Boni, Aurelie; Watkin, Emmanuel; Goubin-Versini, Isabelle; Lamy, Régine; Gérinière, Laurence; Geier, Margaux; Forest, Fabien; Gervais, Radj; Madrosyk, Anne; Guisier, Florian; Serrand, Cécile; Locher, Chrystèle; Dec... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗